医学
甘精胰岛素
伤口愈合
胰岛素
生理盐水
安慰剂
随机对照试验
内科学
外科
胃肠病学
泌尿科
内分泌学
低血糖
病理
替代医学
作者
Mario Aurelio Martínez-Jiménez,Samuel Kolosovas-Machuca,Francisco Alcocer,Luis Carlos Ortiz-Dosal,Mariana C. González-Grijalva,Gibran A. Delsol-Revuelta,Francisco Gaitan-Gaona,Francisco Javier Valadez-Castillo,José L. Ramírez-GarcíaLuna
标识
DOI:10.1016/j.jss.2022.06.070
摘要
To determine whether the local administration of insulin glargine compared with placebo in nondiabetic patients with venous ulcers (VUs) leads to increased wound healing.A randomized controlled trial using a split-plot design was performed in 36 adults with leg VUs >25 cm2 and more than 3 mo of evolution. Each hemi-wound received either 10 UI insulin glargine or saline solution once a day for 7 d. Size of the wounds, thermal asymmetry, the number of blood vessels, and the percentage area of collagen content in wound biopsies were assessed at baseline and after 7 d of treatment. Blood capillary glucose was monitored once a day after the insulin injection.After 7 d of treatment, the hemi-wounds treated with insulin glargine were significantly smaller, had less thermal asymmetry, more blood vessels, and more collagen content than the saline-treated side. Correlation between thermal asymmetry and the number of blood vessels was also found (r2 = 66.2, P < 0.001). No patient presented capillary glucose levels ≤3.3 mmol/L nor any adverse effects.In nondiabetic patients with chronic VUs, the topical administration of insulin glargine seems to be safe and promotes wound healing and tissue repair after 7 d of treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI